✦ LIBER ✦

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia

✍ Scribed by H.J. Mackay; R.J. Buckanovich; H. Hirte; R. Correa; P. Hoskins; J. Biagi; L.P. Martin; G.F. Fleming; R. Morgan; L. Wang; R. Polintan; A.M. Oza

Book ID: 113963549
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 309 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.11.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Aflibercept (VEGF-Trap

Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial

✍ Przemyslaw Twardowski; Walter M. Stadler; Paul Frankel; Primo N. Lara; Christoph 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase II trial of sunitinib in women w

A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia

✍ Castonguay, Vincent; Lheureux, Stephanie; Welch, Stephen; Mackay, Helen J.; Hirt 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 387 KB

Re: Twardowski et al.: Phase II Study of

Re: Twardowski et al.: Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer: A California Cancer Consortium Trial (Urology 2010;76:923-926)

✍ Przemyslaw Twardowski 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 109 KB